Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 50+ Global Mutual Funds
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Diversify into RBI-regulated P2P lending platforms and earn up to 11.5% p.a.
Invest in curated
corporate, gold, and govt. bonds
Earn income
while helping India move to clean energy
Connect with investors, share insights, and grow together.
Master the world of Alternative Investments with our in-depth courses
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning.
Read about our journey and get to know the leadership team at Vested
Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions in the United States. The company offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) knee pain. It is also involved in the development of FX201, a gene therapy product candidate designed to provide on demand production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, a NaV1.7 inhibitor for the management of post-operative pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts. As of November 19, 2021, Flexion Therapeutics, Inc. operates as a subsidiary of Pacira BioSciences, Inc.. more
Time Frame | FLXN | S&P500 |
---|---|---|
1-Week Return | - | 1.27% |
1-Month Return | - | 4.35% |
3-Month Return | - | 24.09% |
6-Month Return | - | 6.24% |
1-Year Return | - | 12.72% |
3-Year Return | - | 60.9% |
5-Year Return | 103% | 99.56% |
10-Year Return | 7.3% | 201.56% |
Time Frame | FLXN | S&P500 |
---|---|---|
1-Week Return | 0.00% | 93.10% |
1-Month Return | 0.00% | 67.88% |
3-Month Return | 0.00% | 139.97% |
6-Month Return | 0.00% | 13.06% |
1-Year Return | 0.00% | 12.72% |
3-Year Return | 0.00% | 17.18% |
5-Year Return | 15.21% | 14.82% |
10-Year Return | 0.71% | 11.67% |
Sector | Weight |
---|---|
Health Care | 100.00% |
Flexion Therapeutics Inc (FLXN) share price today is $24.9899.
Yes, Indians can buy shares of Flexion Therapeutics Inc (FLXN) on Vested. To buy FLXN from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Flexion Therapeutics Inc (FLXN) on Vested. You can start investing in Flexion Therapeutics Inc (FLXN) with a minimum investment of $1.
The stock symbol (or ticker) of Flexion Therapeutics Inc is FLXN.
Yes, you can setup SIP in Flexion Therapeutics Inc shares. Follow the below steps to create the SIP:
Here is the historical performance of FLXN on the Vested app.
You can also access the top holdings, the expense ratio, and the sector breakdown for Flexion Therapeutics Inc on Vested.